NEJM This Week — May 7, 2026 @NEJMgroup
NEJM This Week — May 7, 2026  @NEJMgroup
Uploaded May 2026 | Updated September 2026, 2 weeks ago
This week, we present research on high-risk coronary intervention strategies, targeted therapy for pancreatic cancer, an mRNA influenza vaccine, and treatments for severe scabies and sickle cell disease. We review cerebral amyloid angiopathy and follow a complex case of a disseminated infection. Perspectives address the impact of corporate medicine on medical training and drug pricing policy.
NEJM This Week — May 7, 2026Meet the EquationDr. Glaucomflecken Explains: Triple-Antihypertensive Pill after Intracerebral Hemorrhage (TRIDENT)Intention to Treat: The Race Equation (Audio Preview)Review Article: Antidotes for Anticoagulation Reversal (Key Points)Leading Transformation in Rural Health: How Mayo Clinic Health System Is Redefining Care, Culture...NEJM Interview: Jatin Vyas on the effect of corporatization of academic medical centers on medica...Images in Clinical Medicine: Vibrio vulnificus Necrotizing Soft-Tissue InfectionImage Challenge — April 23, 2026Intention to Treat: When Race Matters (Promo)Are E-Cigarettes Really Safe?When No Ones Watching
NEJM Group |

NEJM This Week — May 7, 2026

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER